230 related articles for article (PubMed ID: 37569592)
1. Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors.
Timofeeva AV; Fedorov IS; Asaturova AV; Sannikova MV; Tregubova AV; Mayboroda OA; Khabas GN; Frankevich VE; Sukhikh GT
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569592
[TBL] [Abstract][Full Text] [Related]
2. Search for New Participants in the Pathogenesis of High-Grade Serous Ovarian Cancer with the Potential to Be Used as Diagnostic Molecules.
Timofeeva AV; Asaturova AV; Sannikova MV; Khabas GN; Chagovets VV; Fedorov IS; Frankevich VE; Sukhikh GT
Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556382
[TBL] [Abstract][Full Text] [Related]
3. Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients.
Petersen PHD; Lopacinska-Jørgensen J; Høgdall CK; Høgdall EV
Mol Biol Rep; 2023 Dec; 50(12):10235-10247. PubMed ID: 37934368
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
[TBL] [Abstract][Full Text] [Related]
5. Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies.
Petrillo M; Zannoni GF; Beltrame L; Martinelli E; DiFeo A; Paracchini L; Craparotta I; Mannarino L; Vizzielli G; Scambia G; D'Incalci M; Romualdi C; Marchini S
Ann Oncol; 2016 Apr; 27(4):625-34. PubMed ID: 26782955
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.
Koleckova M; Ehrmann J; Bouchal J; Janikova M; Brisudova A; Srovnal J; Staffova K; Svoboda M; Slaby O; Radova L; Vomackova K; Melichar B; Veverkova L; Kolar Z
Sci Rep; 2021 Mar; 11(1):5145. PubMed ID: 33664322
[TBL] [Abstract][Full Text] [Related]
7. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer.
Flores-Colón M; Rivera-Serrano M; Reyes-Burgos VG; Rolón JG; Pérez-Santiago J; Marcos-Martínez MJ; Valiyeva F; Vivas-Mejía PE
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612604
[TBL] [Abstract][Full Text] [Related]
9. [Identification of key molecules in miRNA-mRNA regulatory network associated with high-grade serous ovarian cancer recurrence using bioinformatic analysis].
Zhang P; He M; Zeng Y; Cai X
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):8-16. PubMed ID: 36856205
[TBL] [Abstract][Full Text] [Related]
10. Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma.
Yoshida K; Yokoi A; Matsuzaki J; Kato T; Ochiya T; Kajiyama H; Yamamoto Y
Cancer Sci; 2021 Dec; 112(12):4977-4986. PubMed ID: 34618992
[TBL] [Abstract][Full Text] [Related]
11. miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer-Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer.
Szubert M; Nowak-Glück A; Domańska-Senderowska D; Szymańska B; Sowa P; Rycerz A; Wilczyński JR
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139300
[TBL] [Abstract][Full Text] [Related]
12. Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer.
Lopacinska-Jørgensen J; Oliveira DVNP; Wayne Novotny G; Høgdall CK; Høgdall EV
PLoS One; 2021; 16(7):e0255142. PubMed ID: 34320033
[TBL] [Abstract][Full Text] [Related]
13. Small RNA Expression Profiling Reveals hsa-miR-181d-5p Downregulation Associated With TNF-α Overexpression in Sjögren's Syndrome Patients.
Castro I; Carvajal P; Jara D; Aguilera S; Heathcote B; Barrera MJ; Aliaga-Tobar V; Maracaja-Coutinho V; Urzúa U; Quest AFG; González S; Molina C; Hermoso M; González MJ
Front Immunol; 2022; 13():870094. PubMed ID: 35432384
[TBL] [Abstract][Full Text] [Related]
14. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
15. A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer.
Wang L; Zhu MJ; Ren AM; Wu HF; Han WM; Tan RY; Tu RQ
PLoS One; 2014; 9(5):e96472. PubMed ID: 24816756
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Expression Profiling of Epithelial Ovarian Cancer Identifies New Markers of Tumor Subtype.
Rattanapan Y; Korkiatsakul V; Kongruang A; Siriboonpiputtana T; Rerkamnuaychoke B; Chareonsirisuthigul T
Microrna; 2020; 9(4):289-294. PubMed ID: 32703147
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Expression Profiling in Adrenal Myelolipoma.
Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P
J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598
[TBL] [Abstract][Full Text] [Related]
18. microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.
Kunc M; Popęda M; Niemira M; Szałkowska A; Bieńkowski M; Pęksa R; Łacko A; Radecka BS; Braun M; Pikiel J; Litwiniuk M; Pogoda K; Iżycka-Świeszewska E; Krętowski A; Żaczek AJ; Biernat W; Senkus-Konefka E
Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32825530
[TBL] [Abstract][Full Text] [Related]
19. Targeting YAP1 ameliorates progesterone resistance in endometriosis.
Lin SC; Li WN; Lin SC; Hou HT; Tsai YC; Lin TC; Wu MH; Tsai SJ
Hum Reprod; 2023 Jun; 38(6):1124-1134. PubMed ID: 37071897
[TBL] [Abstract][Full Text] [Related]
20. Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.
Zhou J; Gong G; Tan H; Dai F; Zhu X; Chen Y; Wang J; Liu Y; Chen P; Wu X; Wen J
Oncol Rep; 2015 Jun; 33(6):2915-23. PubMed ID: 25962395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
